For almost 50 years, the NHS benefited from easy access to a large market, meaning it’s been first in the queue for the latest innovations. But what impact might Brexit have on medicines, medical devices and life sciences in the UK? Mark Dayan explains, in a blog that was first published in the BMJ on 26 February.

'The Brexiters have no more idea in private than they do in public about what they are doing. Predictions based upon their concealed intent project on to them a competence they simply don’t possess.'

The Health Secretary, announced he has become the world’s leading buyer of fridges, so he can stockpile medicines in the event of no deal – no one wrote that on the side of a bus.